As of 2024-12-14, the Relative Valuation of Aegirbio AB (AEGIR.ST) is (23.05) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.13 SEK, the upside of Aegirbio AB based on Relative Valuation is -17667.4%.
The range of the Relative Valuation is (18.63) - (24.14) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 31.2x | 31.0x |
| Forward P/E multiples | 21.2x - 30.5x | 27.2x |
| Fair Price | (18.63) - (24.14) | (23.05) |
| Upside | -14298.8% - -18500.5% | -17667.4% |
| Date | P/E |
| 2024-11-21 | -0.17 |
| 2024-11-20 | -0.16 |
| 2024-11-19 | -0.16 |
| 2024-11-18 | -0.17 |
| 2024-11-15 | -0.18 |
| 2024-11-14 | -0.17 |
| 2024-11-13 | -0.18 |
| 2024-11-12 | -0.20 |
| 2024-11-11 | -0.18 |
| 2024-11-08 | -0.18 |
| 2024-11-07 | -0.19 |
| 2024-11-06 | -0.19 |
| 2024-11-05 | -0.20 |
| 2024-11-04 | -0.21 |
| 2024-11-01 | -0.21 |
| 2024-10-31 | -0.22 |
| 2024-10-30 | -0.22 |
| 2024-10-29 | -0.23 |
| 2024-10-28 | -0.23 |
| 2024-10-25 | -0.24 |
| 2024-10-24 | -0.26 |
| 2024-10-23 | -0.26 |
| 2024-10-22 | -0.25 |
| 2024-10-21 | -0.25 |
| 2024-10-18 | -0.27 |
| 2024-10-17 | -0.27 |
| 2024-10-16 | -0.27 |
| 2024-10-15 | -0.28 |
| 2024-10-14 | -0.29 |
| 2024-10-11 | -0.29 |
| 2024-10-10 | -0.29 |
| 2024-10-09 | -0.29 |
| 2024-10-08 | -0.29 |
| 2024-10-07 | -0.31 |
| 2024-10-04 | -0.31 |
| 2024-10-03 | -0.30 |
| 2024-10-02 | -0.32 |
| 2024-10-01 | -0.33 |
| 2024-09-30 | -0.32 |
| 2024-09-27 | -0.34 |
| 2024-09-26 | -0.33 |
| 2024-09-25 | -0.34 |
| 2024-09-24 | -0.34 |
| 2024-09-23 | -0.35 |
| 2024-09-20 | -0.35 |
| 2024-09-19 | -0.35 |
| 2024-09-18 | -0.35 |
| 2024-09-17 | -0.35 |
| 2024-09-16 | -0.36 |
| 2024-09-13 | -0.36 |